Newsroom

Sorted by: Latest
-

PHCbi presenta el sistema de expansión celular LiCellGrow™ para respaldar una alta calidad y eficiencia en la producción de terapias celulares y génicas

TOKIO--(BUSINESS WIRE)--La División Biomédica de PHC Corporation (sede central: Chiyoda-ku, Tokio; presidente: Nobuaki Nakamura; en adelante, “PHCbi”), proveedor mundial de soluciones para el almacenamiento de muestras de laboratorio y el cultivo celular y filial de PHC Holdings Corporation (sede central: Chiyoda-ku, Tokio), anunció hoy el lanzamiento de su nuevo sistema de expansión celular LiCellGrow™(*1) para uso en investigación en Japón y otros países seleccionados de todo el mundo(*2). Se...
-

Riassunto: PHCbi presenta il sistema di espansione cellulare LiCellGrow™ a sostegno di una produzione efficiente e di alta qualità di terapie cellulari e genetiche

TOKYO--(BUSINESS WIRE)--PHC Corporation, Biomedical Division (Ufficio centrale: Chiyoda-ku, Tokyo; Presidente: Nobuaki Nakamura; di seguito "PHCbi"), fornitore globale di soluzioni per la conservazione di campioni di laboratorio e di colture cellulari e filiale di PHC Holdings Corporation (Ufficio centrale: Chiyoda-ku, Tokyo), ha annunciato oggi la presentazione del suo nuovo sistema di espansione cellulare LiCellGrow™(*1) a scopo di ricerca in Giappone e in altri paesi selezionati a livello gl...
-

Samenvatting: PHCbi lanceert het celexpansiesysteem LiCellGrow™ om kwaliteitsvolle en efficiënte productie van cel- en gentherapieën te ondersteunen

TOKIO--(BUSINESS WIRE)--PHC Corporation’s Biomedical Division (hoofdzetel: Chiyoda-ku, Tokio; voorzitter: Nobuaki Nakamura; hierna aangeduid als “PHCbi”), een filiaal van PHC Holdings Corporation (hoofdzetel: Chiyoda-ku, Tokio) en wereldwijd aanbieder van oplossingen voor opslag van laboratoriummonsters en celkweek, kondigde vandaag de lancering aan van haar nieuwe celexpansiesysteem LiCellGrow™(*1) voor gebruik bij onderzoek in Japan en een selectie van andere landen in de wereld(*2). Het syst...
-

PHCbi bringt das LiCellGrow™-Zellexpansionssystem auf den Markt, um eine hochwertige, effiziente Produktion von Zell- und Gentherapien zu unterstützen

TOKIO--(BUSINESS WIRE)--Die Biomedical Division der PHC Corporation (Hauptsitz: Chiyoda-ku, Tokio, President: Nobuaki Nakamura; nachstehend „PHCbi“), ein globaler Anbieter von Lösungen für die Laborprobenlagerung und Zellkultivierung sowie Tochtergesellschaft der PHC Holdings Corporation (Sitz: Chiyoda-ku, Tokio), gab heute die Markteinführung seines neuen Zellexpansionssystems LiCellGrow™(*1) für Forschungsanwendungen in Japan und anderen ausgewählten Ländern(*2) bekannt. Entwickelt wurde das...
-

PHCbi lance le système d’expansion cellulaire LiCellGrow™ visant à soutenir la production efficace et de haute qualité de thérapies cellulaires et géniques

TOKYO--(BUSINESS WIRE)--Division biomédicale de PHC Corporation (siège social : Chiyoda-ku, Tokyo ; président : Nobuaki Nakamura ; ci-après « PHCbi »), fournisseur mondial de solutions de stockage d’échantillons de laboratoire et de culture cellulaire et filiale de PHC Holdings Corporation (siège social : Chiyoda-ku, Tokyo), a annoncé aujourd’hui le lancement de son nouveau système d’expansion cellulaire LiCellGrow™(*1) à usage de recherche au Japon et dans certains autres pays du monde(*2). Ce...
-

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Inspire Medical Systems, Inc. (NYSE: INSP). In August of 2025, contrary to the Company’s repeated assurances that it had met all regulatory, technical, and commercial prerequisites for the launch of its Inspire V device, the Company disclosed that the launch faced an "elo...
-

AGL FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has...
-

Stephens Public Finance Strengthens Municipal Expertise With the Addition of Todd Smith

LITTLE ROCK, Ark.--(BUSINESS WIRE)--Stephens today announced that Todd Smith has joined the firm as Vice President in its Public Finance practice. With extensive experience in city management, economic development, and public‑sector leadership, Mr. Smith offers a deep understanding of municipal operations, long‑range infrastructure planning, and strategic community investment. Mr. Smith’s background includes service in city administration in Tennessee, where he directed day-to-day municipal ope...
-

CarMax Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CarMax, Inc. - KMX

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CarMax, Inc. (NYSE: KMX) (“CarMax” or the “Company”). On September 25, 2025, the Company announced its second quarter Fiscal Year 2026 financial results, disclosing, among other things, that retail unit sales had decreased 5.4%, comparable store unit sales had decrea...
-

The Toro Company to Announce Fiscal 2026 First Quarter Results

BLOOMINGTON, Minn.--(BUSINESS WIRE)--The Toro Company to Announce Fiscal 2026 First Quarter Results...